Final patient treated in trial for 1st artificial meniscus implant: 3 key facts to know

To receive FDA clearance for its NUsurface Meniscus Implant, Active Implants enrolled its final patient in the two clinical trials to test the implant’s efficiency.

 Here’s what you need to know:

1. The two clinical trials included 243 patients, including 176 who received the implant.

2. The NUsurface implant is being tested on patients who have persistent knee pain after a meniscus surgery and have exhausted their treatment options. Patients who are too old for repair and too young for a total knee replacement are also included in the trials.

3. If approved by the FDA, the NUsurface will be the first artificial meniscus that does not require fixation to bone or soft tissues.

More articles on orthopedics and TJR:

3 orthopedic surgeons named in $950M kickback scheme, 2 plead guilty

DISC Sports & Spine Center creates minimally invasive spine surgery guide — 3 insights

Kyocera's Aquala artificial hip joint technology recognized by Japan Institute of Invention and Innovation — 3 insights

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast